Posted by Simon Knight on October 31, 2012
The November 2012 edition of the Transplant Trial Watch is now online. Each month the CET staff pick ten recent randomised controlled trials or systematic reviews to appraise the quality and comment on the findings.
This month, trials include Rituximab as induction therapy in renal transplantation, Ephinenphrine for preventing postreperfision syndrome following liver transplantation and perceptions of organ donation after cardiac death in critical care staff.
Don’t forget that the Trial Watch is available on the go with our app for iPhone and Android.
You must be logged in to post a comment.